Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy (AZTEK EXT)

AstraZeneca

Status: Completed

Conditions: Prostate Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00692874

NIS-OHU-ZOL-2007/1

Details and patient eligibility

About

This is an open label, non-interventional quality of life analysis for Zoladex treated prostate cancer patients by investigator's questionnaire

Enrollment: 1,646 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of informed consent
• Early or locally-advanced prostate cancer patients on androgen deprivation therapy
• Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment.

Exclusion criteria

• Allergy to substance of medication
• Prostate cancer patients with advanced disease